Argenx’s Autoimmune Disease Blockbuster-In-Waiting Gets FDA Decision Date

Myasthenia Gravis Is First Target

 
• By Andrew McConaghie
  
Myasthenia gravis
Myasthenia gravis causes muscle weakness, typically affecting the eyes and face.
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip